SlideShare ist ein Scribd-Unternehmen logo
1 von 15
PROTOCoL DESIGN Presented by: RUCHIR JAIN ANKIT DESAI PGDCTM-2009
[object Object]
Protocol is the most important of all clinical trial documents
It is also the first to be prepared and discussed with the investigators.“ It is a confidential document since it contains information on drug “ ,[object Object],A document that states the background, objectives, rationale, design, methodology (including the methods for dealing with AEs,withdrawals etc) and statistical considerations of the study. It also states the conditions under which the study shall be performed and managed. “ ICH GCP E-6 1.44 ”
[object Object],To study the effect of oral sulfonylurea in patient with type -2 diabetes mellitus not previously treated with drug therapy. ,[object Object],To assess the effectiveness of oral sulfonylurea in patients with type-2 diabetes diagnosed keeping in view that the patient is receiving medication for the first time. ,[object Object]
 Open Label,
Treatment (Glimepiride)
Active Control,
Safety/Efficacy Study,[object Object]
blood glucose levels rise due to 		1) Lack of insulin 	production 		2) Insufficient insulin action
[object Object],Glimepiride is a medium-to-long acting sulfonylureaanti-diabetic drug. It is marketed as Amaryl by Sanofi-Aventis and Glyree by Ipca. Glimepiride is the first third-generation sulfonylurea, and is very potent. It is sometimes classified as third-generation, and sometimes classified as second-generation. Mechanism of action: ,[object Object]
Extra-pancreatic effect
Pancreatic effect:
Increase insulin release from pancreas
Suppress secretions of Glucagon

Weitere ähnliche Inhalte

Was ist angesagt?

Clinical pharmacology by prajith.v
Clinical pharmacology by prajith.vClinical pharmacology by prajith.v
Clinical pharmacology by prajith.vPrajith V
 
Pharmaceutical guidelines. Basic principles & statutes
Pharmaceutical guidelines. Basic principles & statutesPharmaceutical guidelines. Basic principles & statutes
Pharmaceutical guidelines. Basic principles & statutesEneutron
 
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...MedicReS
 
Phases 3,4 and 5 of clinical trials
Phases 3,4 and 5 of  clinical trialsPhases 3,4 and 5 of  clinical trials
Phases 3,4 and 5 of clinical trialsDrShrey Bhatia
 
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...PASaskatchewan
 
Introduction to clinical research | B.Pharm
Introduction to clinical research | B.Pharm Introduction to clinical research | B.Pharm
Introduction to clinical research | B.Pharm WorldofPharmacy
 
Presentation on Clinical Trial
Presentation on Clinical TrialPresentation on Clinical Trial
Presentation on Clinical TrialSandeepkarki13
 
antibiotic and using in common infection
antibiotic and using in common infection antibiotic and using in common infection
antibiotic and using in common infection Y Alsfah
 
Clinical pharmacy services-Thao's presentation
Clinical pharmacy services-Thao's presentationClinical pharmacy services-Thao's presentation
Clinical pharmacy services-Thao's presentationHA VO THI
 
Ch 2 basic concepts in pharmacoepidemiology (10 hrs)
Ch 2 basic concepts in pharmacoepidemiology (10 hrs)Ch 2 basic concepts in pharmacoepidemiology (10 hrs)
Ch 2 basic concepts in pharmacoepidemiology (10 hrs)University of Gondar
 
A presentation on different phases of Clinical Trials, Investigational New Dr...
A presentation on different phases of Clinical Trials, Investigational New Dr...A presentation on different phases of Clinical Trials, Investigational New Dr...
A presentation on different phases of Clinical Trials, Investigational New Dr...Gagandeep Jaiswal
 
Essential medicine concepts
Essential medicine conceptsEssential medicine concepts
Essential medicine conceptsViraj Shinde
 

Was ist angesagt? (20)

Clinical pharmacology by prajith.v
Clinical pharmacology by prajith.vClinical pharmacology by prajith.v
Clinical pharmacology by prajith.v
 
Eml p drug
Eml p drugEml p drug
Eml p drug
 
Pharmaceutical guidelines. Basic principles & statutes
Pharmaceutical guidelines. Basic principles & statutesPharmaceutical guidelines. Basic principles & statutes
Pharmaceutical guidelines. Basic principles & statutes
 
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
FDA 2013 Clinical Investigator Training Course: Preparing an IND Application:...
 
Phases 3,4 and 5 of clinical trials
Phases 3,4 and 5 of  clinical trialsPhases 3,4 and 5 of  clinical trials
Phases 3,4 and 5 of clinical trials
 
Role of a Pharmacologist By Dr.Harmanjit Singh
Role of a Pharmacologist By Dr.Harmanjit SinghRole of a Pharmacologist By Dr.Harmanjit Singh
Role of a Pharmacologist By Dr.Harmanjit Singh
 
Clinical trial
Clinical trialClinical trial
Clinical trial
 
Clinical Trial
Clinical TrialClinical Trial
Clinical Trial
 
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
A Little Bit of Everything, Quick & Snappy: Probiotics to Advances in the Car...
 
Introduction to clinical research | B.Pharm
Introduction to clinical research | B.Pharm Introduction to clinical research | B.Pharm
Introduction to clinical research | B.Pharm
 
Presentation on Clinical Trial
Presentation on Clinical TrialPresentation on Clinical Trial
Presentation on Clinical Trial
 
Sibutramine, Oral appetite suppressant
Sibutramine, Oral appetite suppressantSibutramine, Oral appetite suppressant
Sibutramine, Oral appetite suppressant
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
Clinical pharmacology
Clinical pharmacologyClinical pharmacology
Clinical pharmacology
 
antibiotic and using in common infection
antibiotic and using in common infection antibiotic and using in common infection
antibiotic and using in common infection
 
Clinical pharmacy services-Thao's presentation
Clinical pharmacy services-Thao's presentationClinical pharmacy services-Thao's presentation
Clinical pharmacy services-Thao's presentation
 
Ch 2 basic concepts in pharmacoepidemiology (10 hrs)
Ch 2 basic concepts in pharmacoepidemiology (10 hrs)Ch 2 basic concepts in pharmacoepidemiology (10 hrs)
Ch 2 basic concepts in pharmacoepidemiology (10 hrs)
 
A presentation on different phases of Clinical Trials, Investigational New Dr...
A presentation on different phases of Clinical Trials, Investigational New Dr...A presentation on different phases of Clinical Trials, Investigational New Dr...
A presentation on different phases of Clinical Trials, Investigational New Dr...
 
Essential medicine concepts
Essential medicine conceptsEssential medicine concepts
Essential medicine concepts
 
Drug utilisation studies
Drug utilisation studiesDrug utilisation studies
Drug utilisation studies
 

Andere mochten auch

Shillong Lajong presentation at the Sports Journalists Convention in Guwahati
Shillong Lajong presentation at the Sports Journalists Convention in GuwahatiShillong Lajong presentation at the Sports Journalists Convention in Guwahati
Shillong Lajong presentation at the Sports Journalists Convention in GuwahatiAnglianFootball
 
Prevention and management of sports injury
Prevention and management of sports injuryPrevention and management of sports injury
Prevention and management of sports injuryjainamit
 
Types of sports injuries
Types of sports injuriesTypes of sports injuries
Types of sports injuriesStaceyFleming01
 
Sports Injuries Presentation
Sports Injuries PresentationSports Injuries Presentation
Sports Injuries PresentationJasneel Chaddha
 
COACHING SKILLS POWERPOINT
COACHING SKILLS POWERPOINTCOACHING SKILLS POWERPOINT
COACHING SKILLS POWERPOINTAndrew Schwartz
 
Characteristics of a Successful Sports Coach
Characteristics of a Successful Sports CoachCharacteristics of a Successful Sports Coach
Characteristics of a Successful Sports CoachRyan Grogan
 

Andere mochten auch (8)

Shillong Lajong presentation at the Sports Journalists Convention in Guwahati
Shillong Lajong presentation at the Sports Journalists Convention in GuwahatiShillong Lajong presentation at the Sports Journalists Convention in Guwahati
Shillong Lajong presentation at the Sports Journalists Convention in Guwahati
 
Walter Girotto
Walter GirottoWalter Girotto
Walter Girotto
 
Coaching styles
Coaching stylesCoaching styles
Coaching styles
 
Prevention and management of sports injury
Prevention and management of sports injuryPrevention and management of sports injury
Prevention and management of sports injury
 
Types of sports injuries
Types of sports injuriesTypes of sports injuries
Types of sports injuries
 
Sports Injuries Presentation
Sports Injuries PresentationSports Injuries Presentation
Sports Injuries Presentation
 
COACHING SKILLS POWERPOINT
COACHING SKILLS POWERPOINTCOACHING SKILLS POWERPOINT
COACHING SKILLS POWERPOINT
 
Characteristics of a Successful Sports Coach
Characteristics of a Successful Sports CoachCharacteristics of a Successful Sports Coach
Characteristics of a Successful Sports Coach
 

Ähnlich wie Protocal Ppt Ruchir

Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedUeda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedueda2015
 
Scott, Ron Insulin Interventions.pptx
Scott, Ron Insulin    Interventions.pptxScott, Ron Insulin    Interventions.pptx
Scott, Ron Insulin Interventions.pptxssuser0ad194
 
C2 aus diabetes management in g practice australia 2010 11
C2 aus diabetes management in g practice australia 2010 11C2 aus diabetes management in g practice australia 2010 11
C2 aus diabetes management in g practice australia 2010 11Diabetes for all
 
Using PROs to measure secondary endpoints
Using PROs to measure secondary endpointsUsing PROs to measure secondary endpoints
Using PROs to measure secondary endpointsKeith Meadows
 
Degludec insulin journal review
Degludec insulin journal reviewDegludec insulin journal review
Degludec insulin journal reviewSantosh Narayankar
 
COMPARATIVE ANALYSIS OF CHATGPT-4 AND CO-PILOT IN CLINICAL EDUCATION: INSIGHT...
COMPARATIVE ANALYSIS OF CHATGPT-4 AND CO-PILOT IN CLINICAL EDUCATION: INSIGHT...COMPARATIVE ANALYSIS OF CHATGPT-4 AND CO-PILOT IN CLINICAL EDUCATION: INSIGHT...
COMPARATIVE ANALYSIS OF CHATGPT-4 AND CO-PILOT IN CLINICAL EDUCATION: INSIGHT...Vaikunthan Rajaratnam
 
Management of t2 dm beyond glycemic control
Management of t2 dm  beyond glycemic controlManagement of t2 dm  beyond glycemic control
Management of t2 dm beyond glycemic controlalaa wafa
 
Causality Assessment of Adverse Drug Reactions: An overview
Causality Assessment of Adverse Drug Reactions: An overviewCausality Assessment of Adverse Drug Reactions: An overview
Causality Assessment of Adverse Drug Reactions: An overviewDrSahilKumar
 
Dhp manual sample pages 02.11.12
Dhp manual sample pages 02.11.12Dhp manual sample pages 02.11.12
Dhp manual sample pages 02.11.12Keith Meadows
 
Diabetes Management: new drugs and new approaches by Dr Adam Deane
Diabetes Management: new drugs and new approaches by Dr Adam DeaneDiabetes Management: new drugs and new approaches by Dr Adam Deane
Diabetes Management: new drugs and new approaches by Dr Adam DeaneCICM 2019 Annual Scientific Meeting
 
EVALUATION OF GLYCEMIC RESPONSE OF ADDITION OF PIOGLITAZONE TO GLIBENCLAMIDE...
 EVALUATION OF GLYCEMIC RESPONSE OF ADDITION OF PIOGLITAZONE TO GLIBENCLAMIDE... EVALUATION OF GLYCEMIC RESPONSE OF ADDITION OF PIOGLITAZONE TO GLIBENCLAMIDE...
EVALUATION OF GLYCEMIC RESPONSE OF ADDITION OF PIOGLITAZONE TO GLIBENCLAMIDE...Nani Karnam Vinayakam
 
Teneligliptin the next generation gliptin
Teneligliptin   the next generation gliptinTeneligliptin   the next generation gliptin
Teneligliptin the next generation gliptinAKSHATA RAO
 

Ähnlich wie Protocal Ppt Ruchir (20)

Dexlife Handbook DRAFT
Dexlife Handbook DRAFTDexlife Handbook DRAFT
Dexlife Handbook DRAFT
 
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedUeda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayed
 
Scott, Ron Insulin Interventions.pptx
Scott, Ron Insulin    Interventions.pptxScott, Ron Insulin    Interventions.pptx
Scott, Ron Insulin Interventions.pptx
 
Futuro en el tratamiento de la DM2
Futuro en el tratamiento de la DM2Futuro en el tratamiento de la DM2
Futuro en el tratamiento de la DM2
 
C2 aus diabetes management in g practice australia 2010 11
C2 aus diabetes management in g practice australia 2010 11C2 aus diabetes management in g practice australia 2010 11
C2 aus diabetes management in g practice australia 2010 11
 
Using PROs to measure secondary endpoints
Using PROs to measure secondary endpointsUsing PROs to measure secondary endpoints
Using PROs to measure secondary endpoints
 
Degludec insulin journal review
Degludec insulin journal reviewDegludec insulin journal review
Degludec insulin journal review
 
COMPARATIVE ANALYSIS OF CHATGPT-4 AND CO-PILOT IN CLINICAL EDUCATION: INSIGHT...
COMPARATIVE ANALYSIS OF CHATGPT-4 AND CO-PILOT IN CLINICAL EDUCATION: INSIGHT...COMPARATIVE ANALYSIS OF CHATGPT-4 AND CO-PILOT IN CLINICAL EDUCATION: INSIGHT...
COMPARATIVE ANALYSIS OF CHATGPT-4 AND CO-PILOT IN CLINICAL EDUCATION: INSIGHT...
 
Management of t2 dm beyond glycemic control
Management of t2 dm  beyond glycemic controlManagement of t2 dm  beyond glycemic control
Management of t2 dm beyond glycemic control
 
1.1
1.11.1
1.1
 
Causality Assessment of Adverse Drug Reactions: An overview
Causality Assessment of Adverse Drug Reactions: An overviewCausality Assessment of Adverse Drug Reactions: An overview
Causality Assessment of Adverse Drug Reactions: An overview
 
Dhp manual sample pages 02.11.12
Dhp manual sample pages 02.11.12Dhp manual sample pages 02.11.12
Dhp manual sample pages 02.11.12
 
Diabetes Management: new drugs and new approaches by Dr Adam Deane
Diabetes Management: new drugs and new approaches by Dr Adam DeaneDiabetes Management: new drugs and new approaches by Dr Adam Deane
Diabetes Management: new drugs and new approaches by Dr Adam Deane
 
Poster
PosterPoster
Poster
 
EVALUATION OF GLYCEMIC RESPONSE OF ADDITION OF PIOGLITAZONE TO GLIBENCLAMIDE...
 EVALUATION OF GLYCEMIC RESPONSE OF ADDITION OF PIOGLITAZONE TO GLIBENCLAMIDE... EVALUATION OF GLYCEMIC RESPONSE OF ADDITION OF PIOGLITAZONE TO GLIBENCLAMIDE...
EVALUATION OF GLYCEMIC RESPONSE OF ADDITION OF PIOGLITAZONE TO GLIBENCLAMIDE...
 
imeglimin(f). ppt.pptx
imeglimin(f). ppt.pptximeglimin(f). ppt.pptx
imeglimin(f). ppt.pptx
 
Ralfinamide
RalfinamideRalfinamide
Ralfinamide
 
RSSDI
RSSDI RSSDI
RSSDI
 
Diabetes by dr arshid rafiq
Diabetes by dr arshid rafiqDiabetes by dr arshid rafiq
Diabetes by dr arshid rafiq
 
Teneligliptin the next generation gliptin
Teneligliptin   the next generation gliptinTeneligliptin   the next generation gliptin
Teneligliptin the next generation gliptin
 

Kürzlich hochgeladen

How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 

Kürzlich hochgeladen (20)

How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 

Protocal Ppt Ruchir